Gevo, Inc. (NASDAQ:GEVO - Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.45 and traded as high as $1.61. Gevo shares last traded at $1.58, with a volume of 2,919,111 shares.
Analysts Set New Price Targets
Several research analysts have recently commented on the company. UBS Group reduced their target price on Gevo from $3.25 to $1.15 and set a "neutral" rating for the company in a research note on Wednesday, April 2nd. HC Wainwright reiterated a "buy" rating and set a $14.00 target price on shares of Gevo in a research note on Friday, May 30th.
Read Our Latest Stock Report on Gevo
Gevo Price Performance
The company has a 50 day moving average of $1.25 and a 200-day moving average of $1.45. The firm has a market capitalization of $366.53 million, a P/E ratio of -4.25 and a beta of 2.52. The company has a current ratio of 2.04, a quick ratio of 1.71 and a debt-to-equity ratio of 0.31.
Gevo (NASDAQ:GEVO - Get Free Report) last released its quarterly earnings results on Tuesday, May 13th. The energy company reported ($0.09) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.10) by $0.01. The business had revenue of $29.11 million during the quarter, compared to the consensus estimate of $22.19 million. Gevo had a negative return on equity of 16.41% and a negative net margin of 193.87%. On average, sell-side analysts predict that Gevo, Inc. will post -0.42 EPS for the current year.
Insiders Place Their Bets
In other Gevo news, insider Kimberly T. Bowron sold 23,994 shares of Gevo stock in a transaction on Friday, May 30th. The stock was sold at an average price of $1.28, for a total value of $30,712.32. Following the completion of the transaction, the insider directly owned 391,274 shares of the company's stock, valued at $500,830.72. The trade was a 5.78% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Christopher Michael Ryan sold 73,934 shares of Gevo stock in a transaction on Friday, May 30th. The shares were sold at an average price of $1.28, for a total value of $94,635.52. Following the completion of the transaction, the chief operating officer directly owned 1,510,000 shares of the company's stock, valued at $1,932,800. This represents a 4.67% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 469,186 shares of company stock worth $597,229 over the last three months. 4.00% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Gevo
Several hedge funds and other institutional investors have recently added to or reduced their stakes in GEVO. Invesco Ltd. raised its holdings in Gevo by 441.0% in the 4th quarter. Invesco Ltd. now owns 4,289,949 shares of the energy company's stock valued at $8,966,000 after acquiring an additional 3,497,007 shares in the last quarter. Renaissance Technologies LLC acquired a new position in Gevo in the 4th quarter valued at $904,000. Marshall Wace LLP acquired a new position in Gevo in the 4th quarter valued at $812,000. Two Sigma Investments LP raised its holdings in Gevo by 671.3% in the 4th quarter. Two Sigma Investments LP now owns 329,928 shares of the energy company's stock valued at $690,000 after acquiring an additional 287,150 shares in the last quarter. Finally, Schonfeld Strategic Advisors LLC acquired a new position in Gevo in the 4th quarter valued at $562,000. 35.17% of the stock is owned by institutional investors and hedge funds.
Gevo Company Profile
(
Get Free Report)
Gevo, Inc operates as a carbon abatement company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company focuses on transforming renewable energy into energy-dense liquid hydrocarbons that can be used as renewable fuels. It offers renewable gasoline and diesel, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein.
Recommended Stories
Before you consider Gevo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gevo wasn't on the list.
While Gevo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.